SESAM study

You are here

Home » Dataroom » SESAM study
31/05/2015

Aim: Use of self-sampling devices for detection of HPV

Partners: Cancer Registry of Norway, Novosanis nv

The SESAM study is currently ongoing and recruiting women. The aim is to include 300 women, of which 250 CIN2+ women and 50 cancer patients.

HPV detection on different self-sampling methods will be compared, including the Evalyn® brush, the Colli-Pee™, and the FLOQSwab™ and will be evaluated using clinician-based sampling (cytology and HPV test).

Status: recruitment ongoing

  • Currently included: 230 inclusions, including 49 cancer patients
  • First-void urine samples are biobanked, analysis is postponed
  • Usability data collected

Assays: COBAS4800 (Roche) & GeneXpert (Cepheid)

FVU samples are biobanked, no analysis planned yet due to lack of funding by the Cancer Registry; discussions with Roche and Cepheid for analysis are ongoing